Related Experiment Video
Updated: Jul 9, 2025

10:16
Optimization of Flow Cytometric Sorting Parameters for High-Throughput Isolation and Purification of Small Extracellular Vesicles
Published on: January 20, 2023
3.1K
SEVtras delineates small extracellular vesicles at droplet resolution from single-cell transcriptomes
Ruiqiao He1, Junjie Zhu2, Peifeng Ji3
1Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, China.
Nature Methods
|December 4, 2023
Summary
This study introduces SEVtras, a new algorithm for analyzing small extracellular vesicles (sEVs) using single-cell RNA sequencing. SEVtras helps understand cell secretion activity and can indicate early tumor progression.
Area of Science:
- Biotechnology
- Molecular Biology
- Cancer Research
Background:
- Small extracellular vesicles (sEVs) are crucial in biological processes, but their heterogeneity and secretion regulation remain challenging to study.
- High-throughput methods are needed to analyze sEVs and understand cellular secretion behaviors.
Purpose of the Study:
- To develop a novel algorithm, SEVtras, for identifying sEV-containing droplets and quantifying single-cell sEV secretion activity (ESAI).
- To validate SEVtras's performance on simulated and real-world datasets.
- To explore the potential of ESAI as a biomarker for tumor progression.
Main Methods:
- Leveraging droplet-based single-cell RNA sequencing (scRNA-seq).
- Developing and implementing the SEVtras algorithm to identify sEV-containing droplets.
- Applying SEVtras to analyze four tumor scRNA-seq datasets.
Main Results:
- SEVtras effectively identifies sEV-containing droplets and characterizes the secretion activity of individual cells.
- Validated efficacy of SEVtras on both simulated and real scRNA-seq data.
- Demonstrated that ESAI derived from SEVtras can serve as an early indicator of tumor progression.
Conclusions:
- SEVtras provides a powerful tool for dissecting sEV heterogeneity and cellular secretion dynamics.
- The ESAI metric offers valuable extracellular insights into cell heterogeneity and cancer development.
- SEVtras is poised to enhance the analysis of existing and future scRNA-seq datasets for biological discovery.

